Results 241 to 250 of about 22,949 (256)

Fatal adverse drug reactions of anticancer drugs detected by all-case post-marketing surveillance in Japan

Japanese Journal of Clinical Oncology, 2015
Jinichi Mori, Tetsuya Tanimoto, M Kami   +2 more
exaly  

Post-marketing surveillance study of the long-term use of mizoribine for the treatment of lupus nephritis: 2-Year results

Modern Rheumatology, 2018
Hisao Yoshida, Tsutomu Takeuchi, Takeuchi Tsutomu   +2 more
exaly  

Safety and efficacy of canagliflozin in elderly patients with type 2 diabetes mellitus: a 1-year post-marketing surveillance in Japan

Current Medical Research and Opinion, 2018
Kazuyo Sasaki
exaly  

Real-world evidence for the safety of ipragliflozin in elderly Japanese patients with type 2 diabetes mellitus (STELLA-ELDER): final results of a post-marketing surveillance study

Expert Opinion on Pharmacotherapy, 2016
Yasuo Terauchi, Koutaro Yokote
exaly  

Safety of ipragliflozin in elderly Japanese patients with type 2 diabetes mellitus (STELLA-ELDER): Interim results of a post-marketing surveillance study

Expert Opinion on Pharmacotherapy, 2016
Yasuo Terauchi, Koutaro Yokote
exaly  

Zolpidem in Insomnia: A 3-Year Post-Marketing Surveillance Study in Switzerland

Journal of International Medical Research, 1995
exaly  

Interim analysis of post-marketing surveillance of eculizumab for paroxysmal nocturnal hemoglobinuria in Japan

International Journal of Hematology, 2016
Jun-Ichi Nishimura, Naoshi Obara, Shigeru Chiba   +2 more
exaly  

Post-Marketing Surveillance

2002
openaire   +1 more source

Clinical safety and efficacy of “filgrastim biosimilar 2” in Japanese patients in a post-marketing surveillance study

Journal of Infection and Chemotherapy, 2018
Kazuo Tamura, Kiyohiro Nishikawa
exaly  

Improvements for Post-Marketing Surveillance

Emergency Medicine News, 2005
openaire   +1 more source